Abstract
Visceral leishmaniasis (VL) is mainly caused by Leishmania donovani (India and East Africa), and Leishmania infantum (Mediterranean Basin and South America) infections. Although murine models of visceral infection lack the clinicopathological aspects of VL in humans, they have been proven useful at advancing our knowledge in the Leishmania field. Indeed, these models have been used not only to better understand the pathophysiology of the infection but also in drug and vaccine development. This chapter focuses on the protocols used to experimentally infect mice and to quantify parasite burdens in mice infected with L. infantum using limiting dilution methodology of target organs and whole-mouse in vivo imaging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
WHO. Leishmaniasis (2017) [cited 2017 2017-11-30]; Available from: http://www.who.int/leishmaniasis/en/
Alvar J et al (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671
Murray HW et al (2005) Advances in leishmaniasis. Lancet 366:1561–1577
Chappuis F et al (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5:873–882
Fernández-Cotrina J et al (2013) Experimental model for reproduction of canine visceral leishmaniosis by Leishmania infantum. Vet Parasitol 192:118–128
Melby PC et al (2001) The hamster as a model of human visceral Leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol 166:1912–1920
Aslan H et al (2013) A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies. J Infect Dis 207:1328–1338
Loeuillet C et al (2016) Study of Leishmania pathogenesis in mice: experimental considerations. Parasit Vectors 9:144
Scott P, Novais FO (2016) Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol 16:581–592
Leclercq V et al (1996) The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J Immunol 157:4537–4545
Kaye PM, Beattie L (2016) Lessons from other diseases: granulomatous inflammation in leishmaniasis. Semin Immunopathol 38:249–260
Atayde VD (2015) Exosome secretion by the parasitic protozoan Leishmania within the sand fly midgut. Cell Rep 13:957–967
Gomes R, Oliveira F (2012) The immune response to sand fly salivary proteins and its influence on Leishmania immunity. Front Immunol 3:110
Rogers ME (2012) The role of Leishmania proteophosphoglycans in sand fly transmission and infection of the mammalian host. Front Microbiol 3:223
Dey R et al (2018) Gut microbes egested during bites of infected sand flies augment severity of leishmaniasis via inflammasome-derived IL-1β. Cell Host Microbe 23:134–143
Sacks DL, Melby PC (2015) Animal models for the analysis of immune responses to leishmaniasis. Curr Protoc Immunol 108:19.2.1–19.2.24
Faria J et al (2016) Leishmania infantum asparagine synthetase a is dispensable for parasites survival and infectivity. PLoS Negl Trop Dis 10:e0004365
Faria J et al (2016) Disclosing the essentiality of ribose-5-phosphate isomerase B in Trypanosomatids. Sci Rep 6:26937
Costa Lima SA et al (2012) Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis: in vitro and in vivo studies. Nanomedicine (Lond) 7:1839–1849
Tavares J et al (2012) Anti-leishmanial activity of the bisnaphthalimidopropyl derivatives. Parasitol Int 61:360–363
Pérez-Cabezas B et al (2016) Interleukin-27 early impacts Leishmania infantum infection in mice and correlates with active visceral disease in humans. Front Immunol 7:478
Nascimento MS et al (2016) NOD2-RIP2-mediated signaling helps shape adaptive immunity in visceral leishmaniasis. J Infect Dis 214:1647–1657
Arcanjo AF et al (2017) Toll-like receptor 2 is required for inflammatory process development during Leishmania infantum infection. Front Microbiol 8:978
Silvestre R et al (2007) SIR2-deficient Leishmania infantum induces a defined IFN-gamma/IL-10 pattern that correlates with protection. J Immunol 179:3161–3170
Agallou M et al (2017) Identification of BALB/c immune markers correlated with a partial protection to Leishmania infantum after vaccination with a rationally designed multi-epitope cysteine protease A peptide-based Nanovaccine. PLoS Negl Trop Dis 11:e0005311
Banerjee A et al (2018) Live attenuated Leishmania donovani centrin gene-deleted parasites induce IL-23-dependent IL-17-protective immune response against visceral leishmaniasis in a murine model. J Immunol 200:163–176
Buffet PA et al (1995) Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 39:2167–2168
Nicolas L et al (2002) Real-time PCR for detection and quantitation of Leishmania in mouse tissues. J Clin Microbiol 40:1666–1669
Cunha J et al (2013) Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis. Parasit Vectors 6:122
Moreira D et al (2015) Leishmania infantum modulates host macrophage mitochondrial metabolism by hijacking the SIRT1-AMPK axis. PLoS Pathog 11:e1004684
Michel G et al (2011) Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro. PLoS Negl Trop Dis 5:e1323
Reimao JQ et al (2015) Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging. PLoS Negl Trop Dis 9:e0003556
Melo GD et al (2017) New insights into experimental visceral leishmaniasis: real-time in vivo imaging of Leishmania donovani virulence. PLoS Negl Trop Dis 11:e0005924
Costa DM et al (2018) Whole-mouse in vivo bioluminescence imaging applied to drug screening against Leishmania infantum: a reliable method to evaluate efficacy and optimize treatment regimens. bioRxiv. https://doi.org/10.1101/326355
Sereno D et al (2001) DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob Agents Chemother 45:1168–1173
Tavares J et al (2017) In vivo imaging of pathogen homing to the host tissues. Methods 127:37–44
Acknowledgments
We apologize to many researchers in this field whose work we have not been able to cite directly owing to space limitation. This work was supported by funds from the Fundação para a Ciência e Tecnologia (FCT)/Ministério da Educação e Ciência (MEC) cofunded by the European Regional Development Fund (FEDER) under the Partnership agreement PT2020, through the Research Unit No.4293. This work also received funds from project Norte-01-0145-FEDER-000012—Structured program on bioengineered therapies for infectious diseases and tissue regeneration, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the FEDER and the project POCI-01-0145-FEDER-031013 financed by Portugal 2020, under the Programa Operacional Competitividade e Internacionalização (COMPETE 2020). J.T. is an Investigator FCT funded by National funds through FCT and cofunded through European Social Fund within the Human Potential Operating Programme.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Tavares, J., Santarém, N., Cordeiro-da-Silva, A. (2019). Quantification of Leishmania Parasites in Murine Models of Visceral Infection. In: Clos, J. (eds) Leishmania. Methods in Molecular Biology, vol 1971. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9210-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9210-2_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9209-6
Online ISBN: 978-1-4939-9210-2
eBook Packages: Springer Protocols